Cyclica
Share
We advance molecules that embrace the complexity of the disease. Cyclica is the partner of choice for data-driven drug discovery. Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously. We’re also the only company of our kind that integrates science to advance molecules
09/08/2022
In the "bonus" M2M episode, our director of machine learning, Dr. Ali Madani & our machine learning researcher, Dr. Nasim Abdollahi introduce a machine learning framework, using DeepMind's AlphaFold2 structure-augmented protein representations, an essential component in the early AI Drug Discovery process.
Watch the episode here -> https://lnkd.in/gUC2AqKj
08/05/2022
Fresh off the blog!
Our Chief Platform Officer, Dr Stephen MacKinnon, explores new research possibilities following the release of 200 million AlphaFold2 protein structures.
Read the post ➡️ https://bit.ly/3bsR2dD.
07/08/2022
The 3rd episode of our M2M podcast is now available on Spotify!
In this episode, women in STEM trailblazers, Dr. Marti Head & Dr. Melissa Landon discuss small molecules in drug discovery - from the perspective of two brilliant computational scientist.
🎧 here - https://lnkd.in/gzee-yUt
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
207 Queens Quay West #420
Toronto, ON
M5J1A7
